200 related articles for article (PubMed ID: 6316828)
1. [Pathogenicity of various toxinogenic types of Clostridium perfringens administered by mouth to axenic and holoxenic mice].
Hudault S; Bridonneau C; Raibaud P
Ann Microbiol (Paris); 1983; 134B(2):277-83. PubMed ID: 6316828
[TBL] [Abstract][Full Text] [Related]
2. [Antagonistic effect against "Clostridium perfringens" exerted in the digestive tract of gnotobiotic mice by "Clostridium" strains isolated from the microflora of conventional mice (author's transl)].
Hudault S; Raibaud P; Ducluzeau R; Bridonneau C
Ann Microbiol (Paris); 1982; 133(3):443-59. PubMed ID: 6285793
[TBL] [Abstract][Full Text] [Related]
3. Influence of Clostridium perfringens and its toxin in germ-free chickens.
Fukata T; Hadate Y; Baba E; Uemura T; Arakawa A
Res Vet Sci; 1988 Jan; 44(1):68-70. PubMed ID: 2897708
[TBL] [Abstract][Full Text] [Related]
4. Implication of Clostridium difficile and Clostridium perfringens iota toxins in experimental lincomycin-associated colitis of rabbits.
Rehg JE; Pakes SP
Lab Anim Sci; 1982 Jun; 32(3):253-7. PubMed ID: 6285077
[TBL] [Abstract][Full Text] [Related]
5. [Transfer of the cecal flora of the hamster to the germfree C3H mouse: use of this model to study the flora of the anti-Clostridium difficile barrier].
Su WJ; Bourlioux P; Bournaud M; Besnier MO; Fourniat J
Can J Microbiol; 1986 Feb; 32(2):132-6. PubMed ID: 3516351
[TBL] [Abstract][Full Text] [Related]
6. Significance of beta 2-toxigenic clostridium perfringens infections in animals and their predisposing factors--a review.
Schotte U; Truyen U; Neubauer H
J Vet Med B Infect Dis Vet Public Health; 2004 Dec; 51(10):423-6. PubMed ID: 15606864
[TBL] [Abstract][Full Text] [Related]
7. Production of an antibacterial substance in the digestive tract involved in colonization-resistance against Clostridium perfringens.
Crost EH; Pujol A; Ladiré M; Dabard J; Raibaud P; Carlier JP; Fons M
Anaerobe; 2010 Dec; 16(6):597-603. PubMed ID: 20603221
[TBL] [Abstract][Full Text] [Related]
8. Antagonistic effect exerted by three strictly anaerobic strains against various strains of Clostridium perfringens in gnotobiotic rodent intestines.
Yurdusev N; Nicolas JL; Ladire M; Ducluzeau R; Raibaud P
Can J Microbiol; 1987 Mar; 33(3):226-31. PubMed ID: 2882830
[TBL] [Abstract][Full Text] [Related]
9. Clostridium perfringens epsilon toxin inhibits the gastrointestinal transit in mice.
Losada-Eaton DM; Fernandez-Miyakawa ME
Res Vet Sci; 2010 Dec; 89(3):404-8. PubMed ID: 20434186
[TBL] [Abstract][Full Text] [Related]
10. [Detection of toxins of Clostridium perfringens type A in infected animals by using the ELISA test].
Nowakowska M; Bartoszcze M; Matras J
Med Dosw Mikrobiol; 1989; 41(3-4):166-9. PubMed ID: 2561810
[TBL] [Abstract][Full Text] [Related]
11. Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues.
O'Brien DK; Melville SB
Infect Immun; 2004 Sep; 72(9):5204-15. PubMed ID: 15322015
[TBL] [Abstract][Full Text] [Related]
12. Functional and structural characterization of soluble recombinant epsilon toxin of Clostridium perfringens D, causative agent of enterotoxaemia.
Mathur DD; Deshmukh S; Kaushik H; Garg LC
Appl Microbiol Biotechnol; 2010 Oct; 88(4):877-84. PubMed ID: 20676627
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic-induced expression of a cryptic cpb2 gene in equine beta2-toxigenic Clostridium perfringens.
Vilei EM; Schlatter Y; Perreten V; Straub R; Popoff MR; Gibert M; Gröne A; Frey J
Mol Microbiol; 2005 Sep; 57(6):1570-81. PubMed ID: 16135225
[TBL] [Abstract][Full Text] [Related]
14. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C.
Neeson BN; Clark GC; Atkins HS; Lingard B; Titball RW
Microb Pathog; 2007 Oct; 43(4):161-5. PubMed ID: 17604945
[TBL] [Abstract][Full Text] [Related]
15. [Comparative effect of a single or continuous administration of "Saccharomyces boulardii" on the establishment of various strains of "candida" in the digestive tract of gnotobiotic mice].
Ducluzeau R; Bensaada M
Ann Microbiol (Paris); 1982; 133(3):491-501. PubMed ID: 6762128
[TBL] [Abstract][Full Text] [Related]
16. Pathogenicity of Clostridium perfringens for germ-free guinea pigs after oral ingestion.
Horton RE; Madden DL; McCullough NB
Appl Microbiol; 1970 Feb; 19(2):314-6. PubMed ID: 4314377
[TBL] [Abstract][Full Text] [Related]
17. [Experimental infection of axenic mice by "Yersinia enterocolitica" (author's transl)].
Bercovier H; Alonso JM; Destombes P; Mollaret HH
Ann Microbiol (Paris); 1976; 127(4):493-501. PubMed ID: 970831
[TBL] [Abstract][Full Text] [Related]
18. Spore formation and germination of Clostridium perfringens in the digestive tract of holoxenic and axenic mice.
Raibaud P; Ducluzeau R; Dubos F; Sacquet E
J Appl Bacteriol; 1972 Jun; 35(2):177-84. PubMed ID: 4340357
[No Abstract] [Full Text] [Related]
19. "In vivo" and "in vitro" antagonism exerted by two anaerobic strains against strains of clostridium perfringens.
Yurdusev N; Ladire M; Ducluzeau R; Raibaud P
Prog Clin Biol Res; 1985; 181():171-4. PubMed ID: 2862639
[No Abstract] [Full Text] [Related]
20. The enteric toxins of Clostridium perfringens.
Smedley JG; Fisher DJ; Sayeed S; Chakrabarti G; McClane BA
Rev Physiol Biochem Pharmacol; 2004; 152():183-204. PubMed ID: 15517462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
